A US-EU research team has found that a class of compounds that promote tumour cell death can also limit...
Up To Date
Latest News
Celgene will pay $75m upfront to get an option on three cancer programmes developed by Immatics...
Danish microbiology specialist Unibio International plc had completed a US$15m financing round led by West...
US company Freenome will use its multiomics platform to develop response biomarkers to ADC Therapeutics’ Phase...
GlaxoSmithKline plc announced belantamab mafodotin (GSK2857916) met the primary endpoint of overall response...
Researchers from Paul Scherrer Institute in Villingen, Switzerland, and Hoffmann La-Roche AG report in Cell...